Defendants Procter & Gamble and Rite-Aid have won their global motion to exclude the general-causation experts of the last 12 state-court plaintiffs who allege that their exposure to zinc from denture adhesive creams caused them to develop an irreversible neurologic condition known as copper deficiency myeloneuropathy.
The defendants include Procter & Gamble, which makes and distributes Fixodent, and Rite-Aid, which sells the dental adhesive cream.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
